Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-09

Clinical Trial Update: Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus

View source ↗

Summary

The clinical trial evaluating liraglutide as an add-on treatment for Type 1 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Victoza (Liraglutide)

Snippet

Sponsor: University at Buffalo | Conditions: Type 1 Diabetes Mellitus | Status: COMPLETED